Skip to main content

Table 2 Patient and tumour characteristics

From: Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F–FDG-PET-CT and/or diffusion-weighted MRI

Characteristic

No. of patients (%) (n = 46)

Gender

 Male

35 (76.1%)

 Female

11 (23.9%)

Mean age at diagnosis, years (range)

60.4 (44–71)

Oropharyngeal subsite

 Base of tongue

22 (47.8%)

 Tonsil

19 (41.3%)

 Oropharynx nos

5 (10.9%)

HPV-status

 Positive

20 (43.5%)

 Negative

26 (56.5%)

T-stage

 1–2

20 (43.5%)

 3

12 (26.1%)

 4a

14 (30.4)

N-stage

 0

5 (10.9%)

 1

10 (21.7%)

 2a

2 (4.3%)

 2b

20 (43.5%)

 2c

9 (19.6%)

M-stage

 0

46 (100%)

 1

0 (0%)

Smoking

 Never (0–5 pack years)

9 (19.6%)

 Moderate (6–24 pack years)

8 (17.4%)

 Heavy (>24 pack years)

29 (63.0%)

Alcohol consumption

 Never (0)

3 (6.5%)

 Moderate (1–149 unit years)

25 (54.3%)

 Heavy (>149 unit years)

18 (39.1%)

  1. Smoking was defined in pack years (1 pack year = 20 cigarettes a day during 1 year)
  2. Alcohol consumption was defined in unit years (1 unit year = one alcohol-containing consumption a day during 1 year)
  3. Abbreviations: CRT chemoradiotherapy, HPV Human papillomavirus, no number, nos not otherwise specified